Cite
HARVARD Citation
Wan Seman, W. et al. (2016). Switching from sulphonylurea to a sodium‐glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia. Diabetes, obesity & metabolism. 18 (6), pp. 628-632. [Online].